CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.010
-0.040 (-3.81%)
Nov 4, 2024, 4:00 PM EST - Market closed

CytomX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
79104106283303378
Upgrade
Market Cap Growth
-16.69%-1.80%-62.58%-6.69%-19.81%-44.44%
Upgrade
Enterprise Value
-47-75-7069780
Upgrade
Last Close Price
1.011.551.604.336.558.31
Upgrade
PE Ratio
7.50-201.06-1.06-2.40-4.66-2.84
Upgrade
PS Ratio
0.701.031.997.574.4214.03
Upgrade
PB Ratio
-3.04-2.19-1.23-615.53-38.957.39
Upgrade
P/FCF Ratio
-1.10-1.83-0.94-2.34102.63-2.62
Upgrade
P/OCF Ratio
-1.11-1.85-0.95-2.3757.57-2.69
Upgrade
EV/Sales Ratio
-0.35-0.74-1.311.840.112.98
Upgrade
EV/EBITDA Ratio
-5.5617.460.76-0.61-0.09-0.58
Upgrade
EV/EBIT Ratio
-7.4011.600.74-0.59-0.09-0.57
Upgrade
EV/FCF Ratio
0.491.320.62-0.572.48-0.56
Upgrade
Debt / Equity Ratio
-0.38-0.29-0.21-47.22-3.200.54
Upgrade
Debt / FCF Ratio
-0.14-0.25-0.16-0.188.43-0.19
Upgrade
Asset Turnover
0.650.440.180.110.200.07
Upgrade
Quick Ratio
0.981.141.503.934.653.46
Upgrade
Current Ratio
1.001.171.553.984.763.54
Upgrade
Return on Equity (ROE)
-----299.13%-145.96%
Upgrade
Return on Assets (ROA)
1.94%-1.75%-19.54%-20.78%-14.38%-22.15%
Upgrade
Return on Capital (ROIC)
----378.62%-104.99%-84.35%
Upgrade
Earnings Yield
14.05%-0.55%-93.93%-41.01%-21.41%-35.18%
Upgrade
FCF Yield
-109.36%-54.78%-106.42%-42.70%0.97%-38.13%
Upgrade
Buyback Yield / Dilution
-24.87%-12.27%-2.48%-39.01%-1.79%-8.81%
Upgrade
Total Shareholder Return
-24.87%-12.27%-2.48%-39.01%-1.79%-8.81%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.